VISCERAL FATTENING: PATHOGENESIS, CLINICAL SIGNIFICANCE, AND SCIENTIFIC AND PRACTICAL FOUNDATIONS OF ITS REDUCTION
DOI:
https://doi.org/10.17605/Keywords:
Visceral fat, abdominal obesity, insulin resistanceAbstract
This review article analyzes the pathogenetic mechanisms of visceral fat accumulation, its clinical significance, and scientifically based methods for reducing it. The relationship between visceral fat and insulin resistance, chronic low-intensity inflammation, dyslipidemia, arterial hypertension, non-alcoholic fatty liver disease, and cardiovascular diseases is highlighted. The significance of waist circumference and other anthropometric indicators for assessing visceral adiposity, as well as the role of diet, aerobic and strength exercises, sleep, and stress management in reducing visceral fat, were also summarized.
References
1. Després J.P. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126 (10):
1301-1313.
2. Lopes H.F. Visceral adiposity syndrome. Diabetology & Metabolic Syndrome. 2016;8:40.
3. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes.
Nature. 2006;444 (7121):840-846.
4. Kahn B.B., Flier J.S. Obesity and insulin resistance. J Clin Invest. 2000;106 (4):473-481.
5. Hotamisligil G.S. Inflammation and Metabolic Disorders. Nature. 2006;444 (7121):860-867.
6. Janochova K., Haluzik M., Buzga M. Visceral fat and insulin resistance - what do we know? Biomed Pap Med
Fac Univ Palacky Olomouc Czech Repub<3. 2019;163 (1):19-27.
7. Hanlon C.L., Rudser K.D., de Lartigue G. Non-alcoholic fatty liver disease: the role of visceral adipose tissue.
Hepatol Commun. 2022;6 (7):1555-1565.
8. Vettor R., Milan G., Rossato M., Federspil G. Adipocytokines and insulin resistance. Aliment Pharmacol Ther.
2005;22 Suppl 2:3-10.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
